IRIS UniCatt

Cingolani, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.427
EU - Europa 2.898
AS - Asia 2.570
SA - Sud America 670
AF - Africa 112
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9.709
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.261
SG - Singapore 1.205
IT - Italia 640
CN - Cina 615
DE - Germania 594
BR - Brasile 567
SE - Svezia 499
FR - Francia 238
GB - Regno Unito 194
VN - Vietnam 145
IE - Irlanda 141
UA - Ucraina 137
FI - Finlandia 115
IN - India 97
CA - Canada 91
ID - Indonesia 90
PL - Polonia 79
RU - Federazione Russa 66
HK - Hong Kong 63
MX - Messico 51
TR - Turchia 47
AR - Argentina 43
NL - Olanda 42
BD - Bangladesh 36
AT - Austria 34
BE - Belgio 32
JP - Giappone 29
PK - Pakistan 28
IQ - Iraq 27
IR - Iran 25
SA - Arabia Saudita 25
KR - Corea 24
AU - Australia 23
ZA - Sudafrica 22
EG - Egitto 17
PH - Filippine 16
MA - Marocco 15
EC - Ecuador 13
KE - Kenya 13
VE - Venezuela 13
LT - Lituania 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 11
CI - Costa d'Avorio 11
JO - Giordania 11
MY - Malesia 11
UZ - Uzbekistan 11
ES - Italia 10
CO - Colombia 9
CZ - Repubblica Ceca 9
IL - Israele 9
PT - Portogallo 8
CL - Cile 7
PE - Perù 7
NG - Nigeria 6
NP - Nepal 6
EE - Estonia 5
GR - Grecia 5
KG - Kirghizistan 5
PY - Paraguay 5
RO - Romania 5
AZ - Azerbaigian 4
EU - Europa 4
LV - Lettonia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
UY - Uruguay 4
BB - Barbados 3
BG - Bulgaria 3
BZ - Belize 3
KW - Kuwait 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
SD - Sudan 3
TH - Thailandia 3
AO - Angola 2
BY - Bielorussia 2
CM - Camerun 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MG - Madagascar 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
TJ - Tagikistan 2
VA - Santa Sede (Città del Vaticano) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
Totale 9.691
Salva come PNG Salva come JPEG
Città #
Singapore 540
Chandler 486
Ashburn 374
Rome 171
New York 167
Dublin 138
Beijing 115
Dallas 112
Jacksonville 90
Los Angeles 83
Jakarta 82
Milan 80
San Mateo 80
Hefei 74
Chicago 69
The Dalles 69
Nanjing 67
Ann Arbor 61
Wilmington 58
Hong Kong 56
São Paulo 53
Boston 52
Ho Chi Minh City 52
Munich 52
Redmond 51
Helsinki 47
Dearborn 46
Princeton 46
Kraków 45
Moscow 40
Frankfurt am Main 38
London 37
Bremen 34
Hanoi 34
Marseille 33
Boardman 32
North Bergen 32
Houston 31
Nuremberg 31
Brussels 28
Cattolica 28
Tokyo 26
Woodbridge 26
Kent 25
Nürnberg 24
Nanchang 23
Izmir 22
Amsterdam 21
Ottawa 21
Rio de Janeiro 21
Redwood City 20
Seoul 20
Turku 19
Atlanta 18
Buffalo 18
Lappeenranta 18
Lawrence 18
Montreal 18
Seattle 18
Warsaw 18
Fairfield 17
San Francisco 17
Düsseldorf 16
Lancaster 16
Phoenix 16
San Jose 16
Brooklyn 15
Guangzhou 15
Kunming 15
Orem 15
Pune 15
Vienna 15
Denver 14
Johannesburg 14
Norwalk 14
Poplar 14
Santa Clara 14
Stockholm 14
Lahore 13
Mexico City 13
Augusta 12
Dammam 12
Fremont 12
Tianjin 12
Abidjan 11
Amman 11
Baghdad 11
Belo Horizonte 11
Council Bluffs 11
Dhaka 11
Lauterbourg 11
Toronto 11
University Park 11
Washington 11
Wroclaw 11
Bexley 10
Cairo 10
Kish 10
Mountain View 10
Tashkent 10
Totale 4.725
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 498
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 255
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 252
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 208
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 197
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 196
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 196
Plasma levels of Interleukin-6 and Interleukin-10 in preterm neonates evaluated for sepsis 180
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 175
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 156
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma 154
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 151
Residual respiratory impairment after COVID-19 pneumonia 146
COVID-19 atypical Parsonage-Turner syndrome: a case report 145
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 142
Malnutrition in COVID-19 survivors: prevalence and risk factors 140
Residual respiratory impairment after COVID-19 pneumonia 139
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 138
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis 136
Sarilumab use in severe SARS-CoV-2 pneumonia 136
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 133
Cauda Equina Enhancing Lesion in an HIV-Infected Patient. Case Report and Literature Review. 131
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 131
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 129
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure 123
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 121
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 120
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 119
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 117
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients 116
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 115
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital 115
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 114
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 112
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 112
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 110
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 109
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” 107
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 106
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 106
Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy 105
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 105
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 103
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy 102
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 102
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 100
Interpretation systems for genotypic drug resistance of HIV-1 99
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 99
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study 96
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 95
Clinical implications of HIV-1 drug resistance in the neurological compartment 93
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 93
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 93
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 92
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 89
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry 87
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 87
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 87
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 86
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 83
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 81
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition 81
[Treating HIV disease: back to the patient?] 80
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 79
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure. 78
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting 77
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 76
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective 75
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 74
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 73
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: Data from the ICONA foundation study group, years 1997-2013 71
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials 69
Outbreaks of autochthonous Dengue in Lazio region, Italy, August to September 2023: preliminary investigation 68
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 68
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 66
Cerebrospinal fluid drain infection caused by pandrug-resistant Staphylococcus epidermidis successfully treated with ceftaroline in combination with fosfomycin and vancomycin 65
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 64
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 64
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 63
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022 60
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 60
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 59
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 57
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 57
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 47
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 46
Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study 38
Is the rate of virological failure to cART continuing to decline in recent calendar years? 37
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments 14
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 12
Totale 9.841
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021256 0 0 0 0 0 23 34 14 67 24 77 17
2021/2022669 53 44 14 41 32 20 12 99 33 54 110 157
2022/20231.824 190 187 182 335 175 233 86 97 185 70 63 21
2023/2024929 42 198 37 52 40 167 67 36 22 61 83 124
2024/20252.069 36 52 126 102 144 95 138 92 321 192 393 378
2025/20262.749 654 202 384 594 762 153 0 0 0 0 0 0
Totale 9.841